Chiltern, a global contract research organization, is a leading provider of clinical services and solutions in a variety of therapeutic areas with engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,300, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance and Strategic Regulatory services using a collaborative approach for more efficient clinical trials. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®.
|Industry||Clinical Trials, Biopharma, Clinical Analytics, Medical Device and Diagnostics, Source (FSP/Resourcing), Oncology, Respiratory, Anti-infectives/Vaccines, Dermatology, Data Management, eClinical, Biostatistics, SAS Programming, and Clinical Monitoring|
|Key people|| Jim Esinhart - CEO
Richard Pilnik - Chairman of the Board
|Number of employees||1,001-5,000 employees|
- 1 History
- 2 Services
- 3 PHARMACOVIGILANCE SERVICES
- 4 Controversies
- 5 Top 5 Recent Tweets
- 6 Top 5 Recent News Headlines
- 7 Top 5 Lifetime Tweets
- 8 Top 5 Lifetime News Headlines
- 9 Joining our team will allow you to reimagine who you can be, what you can do and where you can go. Every day our employees get to realize the impact of what they do — they see how their contributions to quality of life impact people around the world.
- 10 References
“At Chiltern, we commit our people, processes and technology to your drug discovery ventures. Our teams are fully invested in your trial’s success and in improving the quality of life. We welcome the opportunity to join you in securing research sites, enrolling patients in novel trials and transforming the lives of families around the world.” Jim Esinhart, Ph.D. CEO
- Clinical Development
- Medical & Scientific Affairs
- Data & Analysis
- Strategic Regulatory
- Endocrine & metabolic
- Immunology & rheumatology
- Infections disease & vaccines
- Radiology & nuclear medicine
- Women's health
AE/SAE reconciliation Aggregate analysis and support for safety review committees Case narratives Expedited reporting (IND safety reports, SUSARs, medical device and post-marketing reports) Literature review Periodic reporting (line listings, DSURs, PSURs/PBRERs and PADERs) Receipt and processing of SAE/SADE and AE/ADE reports Reporting to regulatory authorities, EudraVigilance, IRBs/IECs and investigators Safety database Safety management plan Signal detection and analysis Site, team and reporter training
Top 5 Recent Tweets
|September 22, 2018||seatsixtyone||@nickbro76777852 @Sue4AudleyWard @VirginTrains @johnmcdonnellMP @UKLabour @alallbutt @AllisonCGardner… https://t.co/f39KnAcQss|
|September 22, 2018||SusanBeeton||@seatsixtyone @RAIL @nickbro76777852 @Sue4AudleyWard @VirginTrains @johnmcdonnellMP @UKLabour @alallbutt… https://t.co/qH6ipZ0jet|
|September 22, 2018||JOEL461||@VikingDAJ @JohnDelaneyWSC @CML_Cadets @VikingCrew1 @MSADover WHAT IS CHILTERN?|
|September 22, 2018||UKTeddyBears||eBay: Fabulous Antique Old Chiltern Dark Golden Mohair Teddy Bear https://t.co/8lCcn19bge https://t.co/1x8eI10TAN|
|September 21, 2018||VikingDAJ||Chiltern Cadets with John Delaney CEO WSC on Star Breeze @JohnDelaneyWSC @CML_Cadets @VikingCrew1 @MSADover https://t.co/3O3Dd48WIZ|
Top 5 Recent News Headlines
1. CHILTERN ACQUIRES JAPANESE CLINICAL RESEARCH ORGANIZATION INTEGRATED DEVELOPMENT ASSOCIATES CO. LTD.
May 31, 2017
London, U.K., Wilmington, N.C. and Tokyo, Japan; May 31, 2017 — Chiltern, a leading global contract research organization, has acquired Integrated Development Associates Co. Ltd. (IDA), a CRO specializing in integrating Japan and Asia into global drug development.
2. CHILTERN PRESENTS WEBINAR ON IMAGING DIAGNOSTICS AND THERANOSTICS
May 11, 2017
London, U.K., and Wilmington, N.C.; May 11, 2017 — Chiltern, a leading global contract research organization, will host a complimentary Xtalks webinar, “Imaging Diagnostics and Theranostics: Meeting Clinical Development Challenges.” The live session will feature thought leaders from Chiltern speaking about the new tools that have evolved in the imaging diagnostic and theranostic space and the opportunities they provide to improve the diagnosis and treatment of cancers and other diseases.
Top 5 Lifetime Tweets
Top 5 Lifetime News Headlines
At Chiltern, it is our vision to help our clients improve global health. We cannot accomplish that alone. We need the best people in the industry — we need you to contribute your talents and skills so that we can help people lead healthier lives. Work in-house, on contract (for top 20 pharma companies!) or work under a functional service provider agreement — we have options that fit your style.